Sicart Associates LLC Abbott Laboratories Transaction History

Sicart Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $20,414 - $24,674	-200 Reduced 4.89%	3,889 $423,000
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $141,492 - $166,699	-1,300 Reduced 24.12%	4,089 $490,000
Q4 2020 Jan 22, 2021	SELL	$105.0 - $114.42 $210,000 - $228,840	-2,000 Reduced 27.07%	5,389 $590,000
Q4 2017 Jan 17, 2018	BUY	$53.68 - $57.47 $396,641 - $424,645	7,389	7,389 $422,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Sicart Associates LLC with notifications on news.